Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
77 hedge funds and large institutions have $49.5M invested in Genesis Healthcare, Inc. in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 9 closing their positions.
23% more capital invested
Capital invested by funds: $40.2M → $49.5M (+$9.3M)
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
3% more funds holding
Funds holding: 75 → 77 (+2)
5% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 21
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCM
V3 Capital Management
Dallas,
Texas
|
+$881K |
| 2 |
Renaissance Technologies
New York
|
+$464K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$410K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$397K |
| 5 |
Invesco
Atlanta,
Georgia
|
+$287K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$805K |
| 2 |
CPA
Columbia Pacific Advisors
Seattle,
Washington
|
-$443K |
| 3 |
State Street
Boston,
Massachusetts
|
-$380K |
| 4 |
Morgan Stanley
New York
|
-$182K |
| 5 |
BlackRock
New York
|
-$166K |
GEN Hedge Fund Activity: Q1 2019 in Review
77 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q1 2019, worth a combined $49.5M — up 23% from $40.2M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new GEN positions and 9 closed out — a net gain of 2 holders — while 22 added to existing stakes and 21 trimmed.
The largest buyer was V3 Capital Management, adding an estimated $881K. The largest seller was D.E. Shaw & Co, cutting an estimated $805K.
- 77 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q1 2019, up from 75 in Q4 2018.
- Funds reported $49.5M of Genesis Healthcare, Inc. stock for Q1 2019, up 23% quarter-over-quarter.
- 11 funds opened new Genesis Healthcare, Inc. positions in Q1 2019 and 9 closed out, a net change of +2 holders.
- The largest Genesis Healthcare, Inc. buyer in Q1 2019 was V3 Capital Management, an estimated $881K added.
- The largest Genesis Healthcare, Inc. seller in Q1 2019 was D.E. Shaw & Co, an estimated $805K sold.
Based on aggregated 13F filings for Q1 2019.